Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 6Oropharyngeal Neoplasms 5Mouth Neoplasms 5Carcinoma 5Laryngeal Neoplasms 4Nasopharyngeal Carcinoma 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Ganglioneuroblastoma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vulvar Neoplasms 1Uterine Neoplasms 1Testicular Neoplasms 1Teratoma 1Stomatitis 1Stomach Neoplasms 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Sinonasal Squamous Cell Carcinoma 1Seminoma 1Sarcoma 1Resectable Intrahepatic Cholangiocarcinoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Peritoneal Neoplasms 1Osteosarcoma 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Specimen Handling 2Biopsy 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1enfortumab vedotin 1durvalumab 1Vinblastine 1Platinum 1Nephroureterectomy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Renal Pelvis and Ureter Urothelial Carcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡